Japanese Life Sciences Stock News

TSE:8984
TSE:8984REITs

Assessing Daiwa House REIT Investment (TSE:8984) Valuation After Half Year Earnings Release

Earnings release puts Daiwa House REIT Investment (TSE:8984) in focus Daiwa House REIT Investment (TSE:8984) has moved into the spotlight after reporting half year results to February 28, 2026, including revenue of ¥32,063.37 million and net income of ¥12,213.07 million. See our latest analysis for Daiwa House REIT Investment. At a share price of ¥127,400, Daiwa House REIT Investment has a year to date share price return of an 11.10% decline, yet its 1 year total shareholder return of 12.65%...
TSE:8591
TSE:8591Diversified Financial

Assessing ORIX (TSE:8591) Valuation After Recent Share Price Softness And Strong One Year Return

Recent share performance and business profile With no single headline event driving ORIX (TSE:8591) today, investors may focus on how the share price and fundamentals line up, including recent returns, earnings profile, and the breadth of its business segments. See our latest analysis for ORIX. The recent 7 day share price return of a 3.27% decline contrasts with ORIX's 30 day share price return of a 1.64% gain and a 1 year total shareholder return of 73.87%. This suggests positive long term...
TSE:6981
TSE:6981Electronic

Assessing Murata Manufacturing (TSE:6981) Valuation After Its Strong Recent Share Price Momentum

Recent performance snapshot Murata Manufacturing (TSE:6981) has caught investor attention after a strong run, with the share price showing double digit gains over the past month and past 3 months, and a 1 year total return above 100%. See our latest analysis for Murata Manufacturing. This kind of strong short term share price momentum, with a 30 day share price return of 32.58% and a 90 day share price return of 48.14%, sits alongside a 1 year total shareholder return of 126.56%. Taken...
TSE:9147
TSE:9147Logistics

Will Hanoi’s Off‑Airport Cargo Hub Reshape Nippon Express Holdings’ Competitive Edge (TSE:9147)?

Nippon Express Holdings recently held a board meeting on April 17, 2026, to consider and approve entering into a share purchase agreement, following its move to secure a container freight station license for its new off-airport air cargo facility at the Quang Minh Logistics Center in Hanoi, Vietnam. The Hanoi facility allows Nippon Express to consolidate and manage air cargo away from the congested Noi Bai airport terminal, aiming to cut waiting times, tighten cargo control and improve...
TSE:4704
TSE:4704Software

Trend Micro Launches TrendLife And Kaleida As AI Consumer Growth Test

Trend Micro (TSE:4704) has launched TrendLife, a new consumer business brand focused on digital life protection for households. Alongside TrendLife, the company introduced Kaleida, an AI companion designed to help protect families from emerging digital risks. The move expands Trend Micro's consumer cybersecurity offering into AI enabled, always on protection tools for everyday online activity. Trend Micro is best known for its cybersecurity products for consumers, enterprises, and cloud...
TSE:8750
TSE:8750Insurance

Is It Time To Reassess Daiichi Life Group (TSE:8750) After Japan Governance Reforms?

If you are wondering whether Daiichi Life Group's current share price reflects its underlying value, this article walks through what the numbers are really saying about the stock. The share price most recently closed at ¥1,410.5, with returns of 5.7% year to date and 48.6% over 1 year. Meanwhile, the 7 day and 30 day returns of a 3.4% decline and a 1.9% decline hint at a more mixed short term picture. Recent coverage has focused on Daiichi Life Group's role within the Japanese insurance...
TSE:6645
TSE:6645Electronic

Is It Too Late To Consider OMRON (TSE:6645) After Its Recent Share Price Rebound?

If you are wondering whether OMRON is priced attractively right now, the recent share performance and a mixed valuation picture make it a stock worth a closer look. The share price closed at ¥5,093, with returns of 1.9% over 7 days, 13.0% over 30 days, 27.5% year to date and 21.5% over 1 year. This compares with declines of 31.8% over 3 years and 33.1% over 5 years. Recent news around OMRON has focused on the company as a key name in Japan's technology sector. This helps frame how investors...
TSE:4307
TSE:4307IT

Nomura Research Institute (TSE:4307) Q4 EPS Loss Challenges Bullish Margin Recovery Narratives

Latest FY 2026 Results Snapshot Nomura Research Institute (TSE:4307) has just capped FY 2026 with fourth quarter revenue of ¥212.4b and a basic EPS loss of ¥118.43, a sharp contrast to the trailing twelve month EPS of ¥26.62 and net income of ¥15.3b. Over the past several quarters, revenue has moved from ¥196.6b in Q4 FY 2025 to ¥195.8b, ¥201.3b and ¥205.3b, before reaching ¥212.4b in Q4 FY 2026. Quarterly basic EPS shifted from ¥38.40 to ¥45.43, ¥48.09 and ¥51.68, ahead of the latest...
TSE:6954
TSE:6954Machinery

Fanuc (TSE:6954) Margin Strength And 12.9% Earnings Growth Test Valuation Concerns

Fanuc (TSE:6954) closed out FY 2026 with fourth quarter revenue of ¥234.5b and basic EPS of ¥53.24, set against trailing 12 month revenue of ¥857.8b and EPS of ¥178.47. Earnings over the past year improved 12.9% with forecasts pointing to about 7.4% annual growth. Over recent periods the company has seen quarterly revenue move from ¥197.1b in FY 2025 Q3 to ¥234.5b in FY 2026 Q4, with basic EPS over those same quarters ranging from ¥35.21 to ¥53.24. Trailing net margin held at 19.4% versus...
TSE:6723
TSE:6723Semiconductor

Renesas Electronics (TSE:6723) Q1 Profit Rebound Tests Bearish Unprofitability Narrative

Renesas Electronics (TSE:6723) opened Q1 2026 with revenue of ¥380.3 billion and basic EPS of ¥37.57, while trailing twelve month EPS sits at a loss of ¥5.31, underlining that the latest quarterly profit is set against a still-unprofitable year. The company has seen quarterly revenue move from ¥292.6 billion in Q4 2024 to ¥380.3 billion in Q1 2026, with basic EPS ranging from a loss of ¥33.38 in Q2 2025 to ¥58.66 in Q3 2025. Investors are watching how consistently these margins can hold up...
TSE:8604
TSE:8604Capital Markets

Nomura Holdings (TSE:8604) Margin Slippage Tests Long Running Earnings Growth Narrative

Nomura Holdings (TSE:8604) has wrapped up FY 2026 with fourth quarter revenue of ¥577.2b and basic EPS of ¥25.29, setting the tone for how investors assess the latest earnings run. Over recent periods, revenue has moved from ¥452.7b in FY 2025 Q4 to ¥577.2b in FY 2026 Q4, while quarterly basic EPS shifted from ¥24.35 to ¥25.29. On a trailing twelve month basis, EPS and net income reached ¥123.08 and ¥362.1b respectively, supported by revenue of ¥2.17t. With a trailing net margin of 16.7%...
TSE:5423
TSE:5423Metals and Mining

Tokyo Steel Manufacturing (TSE:5423) Margin Decline Reinforces Bearish Narratives On Earnings Quality

Tokyo Steel Manufacturing (TSE:5423) has wrapped up FY 2026 with fourth quarter revenue of ¥66.2b and basic EPS of ¥21.05, setting the tone for a year where trailing twelve month revenue came in at ¥268.1b and EPS at ¥112.55. Over recent periods the company has seen quarterly revenue move from ¥80.4b and EPS of ¥66.02 in FY 2025 Q3 to ¥73.1b and EPS of ¥36.18 in FY 2026 Q1, before settling at FY 2026 Q4 levels. This frames a year where investors are likely to focus on how thinner margins and...
TSE:4519
TSE:4519Pharmaceuticals

Chugai Pharmaceutical (TSE:4519) Q1 Net Margin Near 35% Reinforces Bullish Profitability Narratives

Chugai Pharmaceutical (TSE:4519) opened 2026 with Q1 revenue of ¥321,747 million and basic EPS of ¥70.13, setting the tone off the back of a year where trailing twelve month revenue reached about ¥1.29 trillion and EPS came in at ¥274.77. Over recent quarters the company has seen revenue move from ¥288,459 million and EPS of ¥59.09 in Q1 2025 to ¥346,301 million and EPS of ¥78.04 in Q4 2025, giving you a clear view of the top line and per share earnings trend heading into the latest print...
TSE:1605
TSE:1605Oil and Gas

A Look At Inpex’s (TSE:1605) Valuation After Recent Share Price Pullback And Strong 1 Year Return

Recent performance snapshot Inpex (TSE:1605) has drawn attention after a 2.6% gain over the past day and 2.2% over the past week, in contrast with an 8.3% decline over the past month but a 26.1% rise over the past 3 months. See our latest analysis for Inpex. The recent pullback, including a 1 month share price return of negative 8.3%, sits against a stronger backdrop. A 3 month share price return of 26.1% and a 1 year total shareholder return above 100% suggest that momentum has been building...
TSE:2502
TSE:2502Beverage

A Look At Asahi Group Holdings (TSE:2502) Valuation After Recent Mixed Share Returns

Recent returns and business snapshot Asahi Group Holdings (TSE:2502) has recently drawn attention after a stretch of mixed share returns, including a 0.6% decline in the latest session and weaker performance over the past year. The company operates a broad beverage and food portfolio across Japan, Europe, Oceania, and Southeast Asia, generating revenue of ¥2,926,294 and net income of ¥155,563, with annual revenue growth of 3.9% and net income growth of 10.3%. See our latest analysis for Asahi...
TSE:8031
TSE:8031Trade Distributors

Is It Too Late To Consider Mitsui (TSE:8031) After A 110% One Year Surge?

If you are wondering whether Mitsui's share price still offers value after a strong run, or if most of the opportunity is already priced in, this article breaks down what the current numbers say. Mitsui recently closed at ¥5,784, with a 1-year return of 110.0%, a 3-year return of 197.3% and a very large 5-year gain. However, the stock has seen a 0.3% decline over 7 days and a 7.5% decline over 30 days, while the year-to-date return stands at 21.7%. Recent coverage has focused on Mitsui's...
TSE:3407
TSE:3407Chemicals

Asahi Kasei Expands Pharma Reach With Aicuris Deal And AK1940 Trial

Asahi Kasei (TSE:3407) has completed its acquisition of German biopharmaceutical company Aicuris Anti-infective Cures. The company has also initiated a Phase I clinical trial for AK1940, a new therapy candidate for autoimmune diseases. Both developments mark a shift in focus toward infectious and autoimmune disease treatments within Asahi Kasei's pharmaceutical operations. Asahi Kasei, traditionally known for chemicals, materials, and health care businesses, is steadily building out its...
TSE:7912
TSE:7912Commercial Services

How Investors May Respond To Dai Nippon Printing (TSE:7912) Expanding Its Advanced Automotive Display Films

Dai Nippon Printing Co., Ltd. has announced it will begin mass production in April 2026 of a new decorative film for automotive displays that combines woodgrain-style design with advanced optical performance, initially targeting the Chinese market before moving into Europe, Japan, the United States, South Korea, India and other regions. An interesting angle is DNP’s plan to apply this microfabricated, Electron Beam-coated film beyond car interiors, including exterior auto components and...
TSE:7974
TSE:7974Entertainment

Nintendo (TSE:7974) Is Down 7.5% After Cutting Switch 2 Output Amid Rising Memory Costs – What's Changed

Nintendo recently reported rising memory component costs that it cannot pass on to customers, pressuring margins and forcing a cut in quarterly Switch 2 production from 6 million to 4 million units amid softer demand. An interesting angle is that, despite these operational headwinds, the company is leaning on its sizeable cash reserves to support its longer-term business plans. We’ll now explore how rising memory costs and reduced Switch 2 production are shaping Nintendo’s investment...